This study co-authored by Professor Asif Muneer and Mr Hussain Alnajjar along with their senior researcher Mr Karl Pang, examines real-world data regarding testicular cancer cases in the NHS from 2013 to 2020.
They found that annual incidence rates and patient survival remained consistently high and stable throughout the seven-year period. Most patients were diagnosed through an urgent 2 week wait referral pathway, while surgical intervention served as the primary method of treatment.
The data highlighted that while localised disease carries an excellent prognosis, survival outcomes are generally better for younger patients and those with seminomatous tumors. This comprehensive analysis underscores the value of national registries in monitoring disease trends and ensuring clinical adherence to management guidelines for testicular cancer.
You can read the full study here.
You might also be interested in this audio clip that discusses Testicular Cancer trends and this study – Listen here:
Citation:
Pang KH, Alnajjar HM, Muneer A. Diagnosis, Treatment and Survival From Testicular Cancer: Real-World Data From the National Health Service England Between 2013 and 2020. Clin Genitourin Cancer. 2025 Aug;23(4)
